Product
HyQvia
1 clinical trial
2 indications
Indication
Primary ImmunodeficiencyIndication
Secondary Immune DeficiencyClinical trial
Facilitated Immunoglobulin Administration Registry and Outcomes StudyStatus: Completed, Estimated PCD: 2021-11-30